Skin breakdown and ulceration is a recognized adverse effect of drugs with immunosuppressant activity such as methotrexate. Leflunomide, a newer agent prescribed in the treatment of rheumatoid arthritis, may now be listed among the drugs in this category associated with this adverse drug effect.
No takes yet. Share an insight, caveat, or question.
Christopher McCoy (2002) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: